S-1 S-1 EX-FILING FEES 0002130606 Obsidian Therapeutics, Inc. N/A N/A 0002130606 2026-08-28 2026-08-28 0002130606 1 2026-08-28 2026-08-28 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-1

Obsidian Therapeutics, Inc.

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Common Stock, par value of $0.0001 Other 29,164,045 $ 17.7597 $ 517,944,689.99 0.0001381 $ 71,528.17
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 517,944,689.99

$ 71,528.17

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 71,528.17

Offering Note

1

(A) The amount of shares registered represents an aggregate of 29,164,045 shares of common stock, par value $0.0001 per share, of Obsidian Therapeutics, Inc. (the "Common Stock"), all of which were acquired by the selling stockholders named in the prospectus that forms a part of this registration statement (this "Registration Statement") in a private placement. Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional shares of Common Stock that may be offered or become issuable as a result of stock splits, stock dividends, or other distribution, recapitalization or similar event or transaction effected without the receipt of consideration which results in an increase in the number of outstanding Common Stock. (B) Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(c) under the Securities Act and based upon the average of the high and low sales prices of the Common Stock, as reported on the Nasdaq Capital Market on August 27, 2026, which date is within five business days prior to the filing of this Registration Statement.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims
Fee Offset Sources
Rule 457(p)
Fee Offset Claims
Fee Offset Sources
Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date